Invest in 10,000+ US Stocks and ETFs
* Offering through VF Securities, Inc. (member FINRA/SIPC)
T2 Biosystems, Inc., an in vitro diagnostics company, develops and sells diagnostic products and product candidates in the United States and internationally. Its technology enables detection of pathogens, biomarkers, and other abnormalities in various unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum, cerebral spinal fluid, and urine. The company also offers T2Dx Instrument, a bench-top instrument that runs various diagnostic tests from patient samples; T2Candida panel, a direct-from-blood molecular diagnostic test panel that detects lethal form of common blood stream infections, which cause sepsis and candidemia; T2Bacteria panel, a direct-from-blood molecular diagnostic test panel, which detects bacterial pathogens in blood stream infections; T2Resistance panel, a direct-from-blood test that identifies carbapenem resistance genes; and T2Biothreat, a direct-from-blood molecular diagnostic test panel that runs on the T2Dx Instrument and detects biothreat pathogens. In addition, it is developing T2Cauris panel, a direct-from-blood molecular diagnostic test that runs on the T2Dx Instrument and detects Candida auris; and T2Lyme panel, a direct-from-blood molecular diagnostic test panel that runs on the T2Dx Instrument to identify the bacteria that cause Lyme disease. T2 Biosystems, Inc. was incorporated in 2006 and is headquartered in Lexington, Massachusetts. more
Time Frame | TTOO | Sector | S&P500 |
---|---|---|---|
1-Week Return | -30.58% | -3.72% | -0.05% |
1-Month Return | -29.22% | -1.85% | 2.75% |
3-Month Return | -84.37% | -11.4% | 7.4% |
6-Month Return | -92.96% | -4.41% | 10.47% |
1-Year Return | -90.77% | 4.13% | 27.57% |
3-Year Return | -99.99% | 0.3% | 29.56% |
5-Year Return | -99.99% | 36.62% | 89.3% |
10-Year Return | -100% | 106.81% | 206.09% |
Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | 5YR TREND | |
---|---|---|---|---|---|---|
Total Revenue | 8.34M | 18.13M | 28.06M | 22.30M | 7.19M | [{"date":"2019-12-31","value":29.71,"profit":true},{"date":"2020-12-31","value":64.62,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":79.5,"profit":true},{"date":"2023-12-31","value":25.64,"profit":true}] |
Cost of Revenue | 16.76M | 21.28M | 20.70M | 21.14M | 15.36M | [{"date":"2019-12-31","value":78.77,"profit":true},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":97.29,"profit":true},{"date":"2022-12-31","value":99.34,"profit":true},{"date":"2023-12-31","value":72.19,"profit":true}] |
Gross Profit | (8.43M) | (3.15M) | 7.36M | 1.17M | (8.17M) | [{"date":"2019-12-31","value":-114.59,"profit":false},{"date":"2020-12-31","value":-42.83,"profit":false},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":15.85,"profit":true},{"date":"2023-12-31","value":-111.08,"profit":false}] |
Gross Margin | (101.12%) | (17.37%) | 26.21% | 5.23% | (113.58%) | [{"date":"2019-12-31","value":-385.74,"profit":false},{"date":"2020-12-31","value":-66.28,"profit":false},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":19.94,"profit":true},{"date":"2023-12-31","value":-433.3,"profit":false}] |
Operating Expenses | 43.63M | 38.21M | 50.33M | 56.68M | 41.49M | [{"date":"2019-12-31","value":76.98,"profit":true},{"date":"2020-12-31","value":67.41,"profit":true},{"date":"2021-12-31","value":88.8,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":73.21,"profit":true}] |
Operating Income | (52.06M) | (41.36M) | (42.97M) | (55.51M) | (49.66M) | [{"date":"2019-12-31","value":-5205800000,"profit":false},{"date":"2020-12-31","value":-4135600000,"profit":false},{"date":"2021-12-31","value":-4297300000,"profit":false},{"date":"2022-12-31","value":-5551000000,"profit":false},{"date":"2023-12-31","value":-4966400000,"profit":false}] |
Total Non-Operating Income/Expense | (14.30M) | (10.95M) | (12.74M) | (12.88M) | (6.12M) | [{"date":"2019-12-31","value":-1429600000,"profit":false},{"date":"2020-12-31","value":-1094600000,"profit":false},{"date":"2021-12-31","value":-1274200000,"profit":false},{"date":"2022-12-31","value":-1288300000,"profit":false},{"date":"2023-12-31","value":-611500000,"profit":false}] |
Pre-Tax Income | (59.01M) | (46.80M) | (49.24M) | (62.32M) | (50.08M) | [{"date":"2019-12-31","value":-5900600000,"profit":false},{"date":"2020-12-31","value":-4679800000,"profit":false},{"date":"2021-12-31","value":-4924100000,"profit":false},{"date":"2022-12-31","value":-6231700000,"profit":false},{"date":"2023-12-31","value":-5007700000,"profit":false}] |
Income Taxes | 4.11M | 2.41M | 4.25M | 1.05M | 691.11K | [{"date":"2019-12-31","value":96.52,"profit":true},{"date":"2020-12-31","value":56.65,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":24.75,"profit":true},{"date":"2023-12-31","value":16.25,"profit":true}] |
Income After Taxes | (63.11M) | (49.21M) | (53.49M) | (63.37M) | (50.77M) | [{"date":"2019-12-31","value":-6311200000,"profit":false},{"date":"2020-12-31","value":-4920800000,"profit":false},{"date":"2021-12-31","value":-5349500000,"profit":false},{"date":"2022-12-31","value":-6337000000,"profit":false},{"date":"2023-12-31","value":-5076810500,"profit":false}] |
Income From Continuous Operations | (59.01M) | (46.80M) | (49.24M) | (62.00M) | (49.84M) | [{"date":"2019-12-31","value":-5900600000,"profit":false},{"date":"2020-12-31","value":-4679800000,"profit":false},{"date":"2021-12-31","value":-4924100000,"profit":false},{"date":"2022-12-31","value":-6200300000,"profit":false},{"date":"2023-12-31","value":-4983600000,"profit":false}] |
Income From Discontinued Operations | - | - | - | - | - | [{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}] |
Net Income | (63.11M) | (49.21M) | (53.49M) | (63.37M) | (50.08M) | [{"date":"2019-12-31","value":-6311200000,"profit":false},{"date":"2020-12-31","value":-4920800000,"profit":false},{"date":"2021-12-31","value":-5349500000,"profit":false},{"date":"2022-12-31","value":-6337000000,"profit":false},{"date":"2023-12-31","value":-5007700000,"profit":false}] |
EPS (Diluted) | (64.50) | (23.00) | (15.00) | (14.36) | (8.30) | [{"date":"2019-12-31","value":-6450,"profit":false},{"date":"2020-12-31","value":-2300,"profit":false},{"date":"2021-12-31","value":-1500,"profit":false},{"date":"2022-12-31","value":-1436,"profit":false},{"date":"2023-12-31","value":-830,"profit":false}] |
These ratios help you determine the liquidity of the company. Higher is better.
TTOO | |
---|---|
Cash Ratio | 0.09 |
Current Ratio | 0.40 |
Quick Ratio | 0.24 |
These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.
TTOO | |
---|---|
ROA (LTM) | -90.46% |
ROE (LTM) | -622.14% |
These ratios help you understand the company's liabilities, gauging the riskiness of the investment.
TTOO | |
---|---|
Debt Ratio Lower is generally better. Negative is bad. | 1.65 |
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. | -0.65 |
These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.
TTOO | |
---|---|
Trailing PE | NM |
Forward PE | NM |
P/S (TTM) | 1.07 |
P/B | 14.50 |
Price/FCF | NM |
EV/R | 3.20 |
EV/Ebitda | NM |
PEG | NM |
T2 Biosystms Inc (TTOO) share price today is $0.361
Yes, Indians can buy shares of T2 Biosystms Inc (TTOO) on Vested. To buy T2 Biosystms Inc from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in TTOO stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.
Yes, you can purchase fractional shares of T2 Biosystms Inc (TTOO) via the Vested app. You can start investing in T2 Biosystms Inc (TTOO) with a minimum investment of $1.
You can invest in shares of T2 Biosystms Inc (TTOO) via Vested in three simple steps:
The 52-week high price of T2 Biosystms Inc (TTOO) is $8.38. The 52-week low price of T2 Biosystms Inc (TTOO) is $0.35.
The price-to-earnings (P/E) ratio of T2 Biosystms Inc (TTOO) is
The price-to-book (P/B) ratio of T2 Biosystms Inc (TTOO) is 14.50
The dividend yield of T2 Biosystms Inc (TTOO) is 0.00%
The market capitalization of T2 Biosystms Inc (TTOO) is $10.48M
The stock symbol (or ticker) of T2 Biosystms Inc is TTOO